Autoimmune Encephalomyelitis And Regulatory T Cells
自身免疫性脑脊髓炎和调节性 T 细胞
基本信息
- 批准号:8577267
- 负责人:
- 金额:$ 37.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-25 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAdverse effectsAffectAnti-Inflammatory AgentsAnti-inflammatoryAntigensAutoimmune DiseasesAutomobile DrivingBiochemicalBoxingCell Differentiation processCell NucleusCell TherapyCell physiologyCellsCentral Nervous System DiseasesChronicCombined Modality TherapyComplexCytoplasmDevelopmentDiseaseElementsExhibitsExperimental Autoimmune EncephalomyelitisFamilyGene ExpressionGenesGeneticHealthHumanImmune systemImmunityImmunologicsImmunosuppressionInfectionInflammationInflammatoryInjuryKnowledgeLaboratoriesLymphocyte SubsetLymphoidModelingMultiple SclerosisMusMyelinNerve TissueNuclearPathogenesisPatientsPharmaceutical PreparationsPharmacologic SubstancePhenotypePlayProteinsRegulatory T-LymphocyteRisk FactorsRoleSpecificityStagingT-LymphocyteT-Lymphocyte SubsetsTestingTherapeutic EffectTherapeutic UsesTissuesTransfusionUnited Statesclinical practicedosagegain of functionloss of functionmembernew therapeutic targetpreventprogramspublic health relevancerelating to nervous system
项目摘要
DESCRIPTION (provided by applicant): Multiple sclerosis (MS) is an inflammatory disease of the central nervous system that afflicts approximately 400,000 people in the United States alone. An ideal anti-inflammatory therapy for MS should be one that is neural antigen-specific, i.e., it suppresses only inflammatory cells that cause neural tissue injury but not those that protect against infections. Recently, major advances have been made in our understanding of a naturally occurring lymphocyte subset called regulatory T (Treg) cells that are used precisely by the immune system to perform antigen-specific immunosuppression. They play indispensable roles in maintaining health since their deficiency in mice and humans causes fatal inflammatory diseases. They may also be directly involved in the pathogenesis of MS since their functions and numbers are significantly reduced in patients studied by several groups. More importantly, a number of laboratories including ours have shown that adoptive transfer of myelin-specific Treg cells effectively prevents and ameliorates experimental autoimmune encephalomyelitis, a model for MS, in a myelin-specific manner, not affecting immunity against unrelated antigens. These new advances have led to the recognition that transfusion of myelin-specific Treg cells represents an ideal form of adoptive cell therapy for MS. However, Treg cells are still among the least understood T cell subsets, and consequently the most difficult to use for therapeutic applications. This proposal is inspired by recent discoveries from several laboratories including ours that c-Rel, the lymphoid member of the nuclear factor-?B family and a risk factor for human inflammatory diseases, is a key controller of Treg cell development and function. The objectives of this proposal are to (i) determine how c-Rel turns on Foxp3 gene to initiate Treg cell differentiation, (ii) determine how Foxp3 terminates c-Rel activity to stabilize Treg cell function and (iii) develop a new combination therapy for autoimmune encephalomyelitis by targeting the c-Rel-Foxp3 axis.
描述(由申请人提供):多发性硬化症 (MS) 是一种中枢神经系统炎症性疾病,仅在美国就有大约 400,000 人患病。多发性硬化症的理想抗炎疗法应该是神经抗原特异性的疗法,即它仅抑制引起神经组织损伤的炎症细胞,而不抑制那些防止感染的炎症细胞。最近,我们对一种称为调节性 T (Treg) 细胞的天然淋巴细胞亚群的理解取得了重大进展,免疫系统精确地使用该细胞来执行抗原特异性免疫抑制。它们在维持健康方面发挥着不可或缺的作用,因为小鼠和人类缺乏它们会导致致命的炎症性疾病。它们也可能直接参与多发性硬化症的发病机制,因为在几组研究的患者中,它们的功能和数量显着减少。更重要的是,包括我们在内的许多实验室已经表明,髓磷脂特异性Treg细胞的过继转移可以以髓磷脂特异性的方式有效预防和改善实验性自身免疫性脑脊髓炎(多发性硬化症的一种模型),而不影响针对无关抗原的免疫力。这些新进展使人们认识到,髓磷脂特异性 Treg 细胞的输注代表了多发性硬化症过继性细胞疗法的理想形式。然而,Treg 细胞仍然是人们最不了解的 T 细胞亚群之一,因此最难用于治疗应用。这一提议的灵感来自于包括我们在内的多个实验室的最新发现,即 c-Rel(核因子-βB 家族的淋巴成员,也是人类炎症性疾病的危险因素)是 Treg 细胞发育和功能的关键控制器。该提案的目标是(i)确定c-Rel如何开启Foxp3基因以启动Treg细胞分化,(ii)确定Foxp3如何终止c-Rel活性以稳定Treg细胞功能,以及(iii)通过靶向c-Rel-Foxp3轴开发一种新的自身免疫性脑脊髓炎联合疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Youhai H Chen其他文献
Maintaining immunological tolerance with Foxp3
利用 Foxp3 维持免疫耐受
- DOI:
10.1038/cr.2007.84 - 发表时间:
2007-10-19 - 期刊:
- 影响因子:25.900
- 作者:
Lauren E Mays;Youhai H Chen - 通讯作者:
Youhai H Chen
Regulation of inflammation and tumorigenesis by the TIPE family of phospholipid transfer proteins
磷脂转移蛋白 TIPE 家族对炎症和肿瘤发生的调节作用
- DOI:
10.1038/cmi.2017.4 - 发表时间:
2017-03-13 - 期刊:
- 影响因子:19.800
- 作者:
Jason R Goldsmith;Youhai H Chen - 通讯作者:
Youhai H Chen
Youhai H Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Youhai H Chen', 18)}}的其他基金
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis
自身免疫性脑脊髓炎的转录检查点
- 批准号:
9901072 - 财政年份:2019
- 资助金额:
$ 37.6万 - 项目类别:
Leukocyte Activation and Migration in Autoimmune Encephalomyelitis
自身免疫性脑脊髓炎中的白细胞激活和迁移
- 批准号:
9424637 - 财政年份:2016
- 资助金额:
$ 37.6万 - 项目类别:
Autoimmune Encephalomyelitis And Regulatory T Cells
自身免疫性脑脊髓炎和调节性 T 细胞
- 批准号:
9265771 - 财政年份:2013
- 资助金额:
$ 37.6万 - 项目类别:
Regulation of Immunity and Inflammation by TIPE2
TIPE2 对免疫和炎症的调节
- 批准号:
8240423 - 财政年份:2009
- 资助金额:
$ 37.6万 - 项目类别:
Regulation of Immunity and Inflammation by TIPE2
TIPE2 对免疫和炎症的调节
- 批准号:
7580297 - 财政年份:2009
- 资助金额:
$ 37.6万 - 项目类别:
Regulation of Immunity and Inflammation by TIPE2
TIPE2 对免疫和炎症的调节
- 批准号:
7802078 - 财政年份:2009
- 资助金额:
$ 37.6万 - 项目类别:
Regulation of Immunity and Inflammation by TIPE2
TIPE2 对免疫和炎症的调节
- 批准号:
8049145 - 财政年份:2009
- 资助金额:
$ 37.6万 - 项目类别:
Regulation of Immunity and Inflammation by TIPE2
TIPE2 对免疫和炎症的调节
- 批准号:
8436250 - 财政年份:2009
- 资助金额:
$ 37.6万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 37.6万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 37.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 37.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 37.6万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 37.6万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 37.6万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 37.6万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 37.6万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 37.6万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 37.6万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




